Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristoffer Peterson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Medical Physics|May 16, 2023
Surface guided electron FLASH radiotherapy for canine cancer patientsAnnika Mannerberg, Elise Konradsson, Malin Kügele, et al.
Journal of Medicinal Chemistry|December 29, 2017
Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High SelectivityKristoffer Peterson, Rohit Kumar, Olof Stenström, et al.
International Journal of Molecular Sciences|June 27, 2024
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon ResonanceHenry Kim, Louis Kretz, Céline Ronin, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2023
Evaluating the affinity and kinetics of small molecule glycomimetics for human and mouse galectin-3 using surface plasmon resonanceHenry Kim, Nathalie Weidner, Céline Ronin, et al.
JACS Au|September 1, 2021
Entropy-Entropy Compensation between the Protein, Ligand, and Solvent Degrees of Freedom Fine-Tunes Affinity in Ligand Binding to Galectin-3CJohan Wallerstein, Vilhelm Ekberg, Majda Misini Ignjatović, et al.
Journal of Medicinal Chemistry|December 18, 2019
<i>In Vivo Veritas</i>: <sup>18</sup>F-Radiolabeled Glycomimetics Allow Insights into the Pharmacological Fate of Galectin-3 InhibitorsKlas Bratteby, Edvard Torkelsson, Elina Tampio L'Estrade, et al.
Journal of Medicinal Chemistry|December 12, 2024
Development and Characterization of a High-Affinity Selective Galectin-3 Mouse Tool Compound in Mouse Models of CancerKristoffer Peterson, Ulf J Nilsson, Lise Gravelle, et al.
Journal of Medicinal Chemistry|April 29, 2026
An Orally Available Halothiazole Glycomimetic as a Cancer-Targeting Dual Galectin-1 and Galectin-3 InhibitorFredrik R Zetterberg, Kristoffer Peterson, Ulf J Nilsson, et al.
Journal of Medicinal Chemistry|September 26, 2022
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic DiseaseFredrik R Zetterberg, Alison MacKinnon, Thomas Brimert, et al.
Journal of Medicinal Chemistry|May 28, 2024
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung CancerFredrik R Zetterberg, Kristoffer Peterson, Ulf J Nilsson, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Medical Physics|May 16, 2023
Surface guided electron FLASH radiotherapy for canine cancer patientsAnnika Mannerberg, Elise Konradsson, Malin Kügele, et al.
Journal of Medicinal Chemistry|December 29, 2017
Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High SelectivityKristoffer Peterson, Rohit Kumar, Olof Stenström, et al.
International Journal of Molecular Sciences|June 27, 2024
Determining the Affinity and Kinetics of Small Molecule Inhibitors of Galectin-1 Using Surface Plasmon ResonanceHenry Kim, Louis Kretz, Céline Ronin, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 29, 2023
Evaluating the affinity and kinetics of small molecule glycomimetics for human and mouse galectin-3 using surface plasmon resonanceHenry Kim, Nathalie Weidner, Céline Ronin, et al.
JACS Au|September 1, 2021
Entropy-Entropy Compensation between the Protein, Ligand, and Solvent Degrees of Freedom Fine-Tunes Affinity in Ligand Binding to Galectin-3CJohan Wallerstein, Vilhelm Ekberg, Majda Misini Ignjatović, et al.
Journal of Medicinal Chemistry|December 18, 2019
<i>In Vivo Veritas</i>: <sup>18</sup>F-Radiolabeled Glycomimetics Allow Insights into the Pharmacological Fate of Galectin-3 InhibitorsKlas Bratteby, Edvard Torkelsson, Elina Tampio L'Estrade, et al.
Journal of Medicinal Chemistry|December 12, 2024
Development and Characterization of a High-Affinity Selective Galectin-3 Mouse Tool Compound in Mouse Models of CancerKristoffer Peterson, Ulf J Nilsson, Lise Gravelle, et al.
Journal of Medicinal Chemistry|April 29, 2026
An Orally Available Halothiazole Glycomimetic as a Cancer-Targeting Dual Galectin-1 and Galectin-3 InhibitorFredrik R Zetterberg, Kristoffer Peterson, Ulf J Nilsson, et al.
Journal of Medicinal Chemistry|September 26, 2022
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic DiseaseFredrik R Zetterberg, Alison MacKinnon, Thomas Brimert, et al.
Journal of Medicinal Chemistry|May 28, 2024
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung CancerFredrik R Zetterberg, Kristoffer Peterson, Ulf J Nilsson, et al.
Pageof 2